We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

donderdag 1 maart 2018

Nature Reviews Urology - Table of Contents alert Volume 15 Issue 3

If you are unable to see the message below, click here to view.
Nature Reviews Urology
March 2018 Volume 15 Number 3 Advertisement
Nature Reviews Urology cover
2016 2-year Impact Factor 7.735 Journal Metrics 2-year Median 5
In this issue
Research Highlights
News and Views
Also this month
 Featured article:
Labiaplasty: motivation, techniques, and ethics
Müjde Özer, Indiana Mortimore, Elise P. Jansma & Margriet G. Mullender

Do you have a career question?
The Naturejobs podcast features one-on-one Q&As, panel discussions and other exclusive content to help scientists with their careers. Hosted on the Naturejobs blog, the podcast is also available on iTunes and Soundcloud. 

Listen today!

Recommend to library
Nature Collection: Gut-brain axis 

This Nature Collection brings together Research, Reviews and News from across the Nature Research journals and presents a selection of articles covering key aspects of the gut-brain axis including the gut microbiota and immune, neuroendocrine and neural factors. 

Access this collection >>

Produced with support from: 
Comment: Stepwise sexual development of adolescents: the Dutch approach to sexuality education
Sanderijn van der Doef & Jo Reinders

Published online: 31 January 2018
p133 | doi:10.1038/nrurol.2018.3

Dutch adolescents develop their sexuality in a stepwise manner, gradually progressing from first kiss to first sexual intercourse. Adolescents who follow a stepwise sexual development are more confident and engage in less risky sexual behaviour than those who do not. Thus, the stepwise 'sexual career' is an excellent model for guiding development of age-appropriate sex education.

Full Text | PDF


Microbiota: Bacteriophage diversity in the urinary microbiome
Published online: 20 February 2018
p135 | doi:10.1038/nrurol.2018.23


Infection: Vaginal microbiota and infectious infertility
Published online: 31 January 2018
p136 | doi:10.1038/nrurol.2018.11


Prostate cancer: PROMs suggest a festival of benefits in LATITUDE
Published online: 31 January 2018
p136 | doi:10.1038/nrurol.2018.12


Imaging: Predicting 68Ga-PSMA-PET-CT positivity for recurrent disease
Published online: 13 February 2018
p137 | doi:10.1038/nrurol.2018.15


Bladder cancer: Improving NMIBC risk stratification
Published online: 06 February 2018
p138 | doi:10.1038/nrurol.2018.13


Prostate cancer: Developing CAR T cell therapy
Published online: 23 January 2018
p138 | doi:10.1038/nrurol.2018.4


Prostate cancer: Revealing mechanisms of resistance
Published online: 23 January 2018
p138 | doi:10.1038/nrurol.2018.7




Bladder cancer: IMvigor211 trial outcomes reported | Prostate cancer: Utility of ADT during early salvage radiotherapy | Bladder cancer: Activity and safety of avelumab in JAVELIN | Prostate cancer: Predicting risk of metastasis after prostatectomy

Nature Reviews Urology
JOBS of the week
EPFL Life Sciences Early Independence Research Scholar (ELIFR)
Ecole Polytechnique F�d�rale de Lausanne (EPFL)
More Science jobs from
Nature Reviews Urology
The 4th Friends of Israel Urological Symposium
Tel Aviv, Israel
More science events from
Urothelial cancer: Optimizing and integrating cisplatin-based chemotherapy across the disease spectrum
Jay D. Raman

Published online: 16 January 2018
p139 | doi:10.1038/nrurol.2017.213

Data suggest that chemotherapy is a sound treatment option for urothelial cancer across the disease spectrum. However, despite a twofold increase in survival in patients receiving chemotherapy, it does not seem to be offered to all patients.
Full Text | PDF

Prostate cancer: A valuable tool for prediction of repeat biopsy pathology
Pierre Karakiewicz & Sebastiano Nazzani

Published online: 28 December 2017
p140 | doi:10.1038/nrurol.2017.216

Multiparametric MRI (mpMRI) findings are not always accurate in patients with a previous negative prostate biopsy. Truong et al. have developed a nomogram to identify patients with previous negative prostate biopsy who are at elevated risk of harbouring benign histology and should undergo repeat biopsy.
Full Text | PDF

A practical guide to bladder cancer pathology
Eva Compérat et al.

Published online: 31 January 2018
p143 | doi:10.1038/nrurol.2018.2

Comperat et al. review problematic aspects in the pathological assessment of urothelial tumours, evaluating unresolved questions in bladder cancer grading, staging, and tissue handling. They also discuss the incorporation of new molecular and genomic markers into the routine histological work-up.
Abstract | Full Text | PDF

Bladder biomechanics and the use of scaffolds for regenerative medicine in the urinary bladder
Fatemeh Ajalloueian et al.

Published online: 13 February 2018
p155 | doi:10.1038/nrurol.2018.5

Clinical conditions that cause poor bladder compliance, reduced capacity, and incontinence can require bladder augmentation or use of regenerative techniques and scaffolds. Replicating an organ that is under frequent mechanical loading and unloading needs particular attention to its biomechanical requirements. In this Review, the authors describe the biomechanics of the bladder and discuss how different scaffolds and techniques can be assessed to determine the best possible approach to bladder augmentation.
Abstract | Full Text | PDF

Labiaplasty: motivation, techniques, and ethics
Müjde Özer, Indiana Mortimore, Elise P. Jansma & Margriet G. Mullender

Published online: 06 February 2018
p175 | doi:10.1038/nrurol.2018.1

Labiaplasty is attracting increasing attention in the media and in online forums. How to manage a request for this surgery is controversial, and the indications for and outcomes of labiaplasty have not yet been systematically assessed. In this Review, Ozer and colleagues discuss our current knowledge of this surgery.
Abstract | Full Text | PDF

HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer
Daniel Hettel & Nima Sharifi

Published online: 12 December 2017
p191 | doi:10.1038/nrurol.2017.201

Hettel and Sharifi discuss how germline HSD3B1 1245A>C variant status influences outcomes of men with prostate cancer receiving androgen deprivation therapy, indicating its utility as a predictive biomarker. Metabolic effects of variant HSD3B1 status highlight a potential requirement to modify current treatment frameworks.
Abstract | Full Text | PDF

Key Advances in Medicine eBook from Nature Reviews ? FREE to download!

This essential resource summarizes the ground-breaking clinical and biomedical discoveries of 2017 and highlights the trends to watch out for in 2018, making it a must read eBook for anyone with an interest in medical science.

Download for free.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events
Nature Reviews Urology was previously published as Nature Clinical Practice Urology.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature